Literature DB >> 20217954

Soft tissue sarcomas with complex genomic profiles.

Louis Guillou1, Alain Aurias.   

Abstract

Soft tissue sarcomas (STS) with complex genomic profiles (50% of all STS) are predominantly composed of spindle cell/pleomorphic sarcomas, including leiomyosarcoma, myxofibrosarcoma, pleomorphic liposarcoma, pleomorphic rhabdomyosarcoma, malignant peripheral nerve sheath tumor, angiosarcoma, extraskeletal osteosarcoma, and spindle cell/pleomorphic unclassified sarcoma (previously called spindle cell/pleomorphic malignant fibrous histiocytoma). These neoplasms show, characteristically, gains and losses of numerous chromosomes or chromosome regions, as well as amplifications. Many of them share recurrent aberrations (e.g., gain of 5p13-p15) that seem to play a significant role in tumor progression and/or metastatic dissemination. In this paper, we review the cytogenetic, molecular genetic, and clinicopathologic characteristics of the most common STS displaying complex genomic profiles. Features of diagnostic or prognostic relevance will be discussed when needed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20217954     DOI: 10.1007/s00428-009-0853-4

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  106 in total

Review 1.  Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors.

Authors:  Avery A Sandberg; Julia A Bridge
Journal:  Cancer Genet Cytogenet       Date:  2003-08

Review 2.  Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma.

Authors:  Avery A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  2004-11

3.  Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group.

Authors:  F Mertens; P Dal Cin; I De Wever; C D Fletcher; N Mandahl; F Mitelman; J Rosai; A Rydholm; R Sciot; G Tallini; H van Den Berghe; R Vanni; H Willén
Journal:  J Pathol       Date:  2000-01       Impact factor: 7.996

4.  Leiomyosarcomas and most malignant fibrous histiocytomas share very similar comparative genomic hybridization imbalances: an analysis of a series of 27 leiomyosarcomas.

Authors:  J Derré; R Lagacé; A Nicolas; A Mairal; F Chibon; J M Coindre; P Terrier; X Sastre; A Aurias
Journal:  Lab Invest       Date:  2001-02       Impact factor: 5.662

Review 5.  Evaluation of biological potential of smooth muscle tumours.

Authors:  M Miettinen; J F Fetsch
Journal:  Histopathology       Date:  2006-01       Impact factor: 5.087

6.  Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas.

Authors:  Matthieu Bui Nguyen Binh; Louis Guillou; Isabelle Hostein; Marie Christine Château; Francoise Collin; Alain Aurias; Bui Nguyen Binh; Eberhard Stoeckle; Jean-Michel Coindre
Journal:  Am J Surg Pathol       Date:  2007-10       Impact factor: 6.394

7.  Prognostic factors of myxofibrosarcomas: implications of margin status, tumor necrosis, and mitotic rate on survival.

Authors:  Ching-Nan Lin; Shin-Cheng Chou; Chien-Feng Li; Kun-Bow Tsai; Wen-Chung Chen; Ching-Yeh Hsiung; Cheng-Fang Yen; Hsuan-Ying Huang
Journal:  J Surg Oncol       Date:  2006-03-15       Impact factor: 3.454

8.  Prognostic significance of ezrin expression in pleomorphic malignant fibrous histiocytoma.

Authors:  Min Suk Kim; Wan Hyeong Cho; Won Seok Song; Soo-Yong Lee; Dae-Geun Jeon
Journal:  Anticancer Res       Date:  2007 Mar-Apr       Impact factor: 2.480

9.  Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH.

Authors:  S Selvarajah; M Yoshimoto; O Ludkovski; P C Park; J Bayani; P Thorner; G Maire; J A Squire; M Zielenska
Journal:  Cytogenet Genome Res       Date:  2008-10-14       Impact factor: 1.636

10.  Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant.

Authors:  T Mentzel; E Calonje; C Wadden; R S Camplejohn; A Beham; M A Smith; C D Fletcher
Journal:  Am J Surg Pathol       Date:  1996-04       Impact factor: 6.394

View more
  46 in total

1.  A case of myxofibrosarcoma of the maxilla with difficulty in preoperative diagnosis.

Authors:  Susumu Nakahara; Hirokazu Uemura; Tomoyuki Kurita; Motoyuki Suzuki; Takashi Fujii; Yasuhiko Tomita; Kunitoshi Yoshino
Journal:  Int J Clin Oncol       Date:  2011-08-10       Impact factor: 3.402

Review 2.  Role of genetic and molecular profiling in sarcomas.

Authors:  Scott M Norberg; Sujana Movva
Journal:  Curr Treat Options Oncol       Date:  2015-05

3.  HIF-1 Alpha Regulates the Response of Primary Sarcomas to Radiation Therapy through a Cell Autonomous Mechanism.

Authors:  Minsi Zhang; Qiong Qiu; Zhizhong Li; Mohit Sachdeva; Hooney Min; Diana M Cardona; Thomas F DeLaney; Tracy Han; Yan Ma; Lixia Luo; Olga R Ilkayeva; Ki Lui; Amanda G Nichols; Christopher B Newgard; Michael B Kastan; Jeffrey C Rathmell; Mark W Dewhirst; David G Kirsch
Journal:  Radiat Res       Date:  2015-05-14       Impact factor: 2.841

Review 4.  Molecular profiling of sarcomas: new vistas for precision medicine.

Authors:  Tariq Al-Zaid; Wei-Lien Wang; Neeta Somaiah; Alexander J Lazar
Journal:  Virchows Arch       Date:  2017-06-29       Impact factor: 4.064

5.  Multiple sites of highly amplified DNA sequences detected by molecular cytogenetic analysis in HS-RMS-2, a new pleomorphic rhabdomyosarcoma cell line.

Authors:  Eiji Takaoka; Hiroshi Sonobe; Kunihiro Akimaru; Shuji Sakamoto; Taro Shuin; Masanori Daibata; Takahiro Taguchi; Akira Tominaga
Journal:  Am J Cancer Res       Date:  2012-02-19       Impact factor: 6.166

6.  A retrospective, single-center cohort study on 65 patients with primary retroperitoneal liposarcoma.

Authors:  Yi-Xi Wu; Jun-Yan Liu; Jia-Jia Liu; Peng Yan; Bo Tang; You-Hong Cui; Yong-Liang Zhao; Yan Shi; Ying-Xue Hao; Pei-Wu Yu; Feng Qian
Journal:  Oncol Lett       Date:  2017-12-05       Impact factor: 2.967

Review 7.  [Pleomorphic high-grade soft tissue sarcomas: is the subclassification up to date?].

Authors:  G Mechtersheimer; M Renner; R Penzel; P Schirmacher
Journal:  Pathologe       Date:  2011-02       Impact factor: 1.011

8.  Primary myxofibrosarcoma of the parotid: case report.

Authors:  Xu Li; Xin Chen; Zhao-Hui Shi; Yang Chen; Jing Ye; Li Qiao; Jian-Hua Qiu
Journal:  BMC Cancer       Date:  2010-06-01       Impact factor: 4.430

9.  DNA copy number changes in human malignant fibrous histiocytomas by array comparative genomic hybridisation.

Authors:  Stine H Kresse; Hege O Ohnstad; Bodil Bjerkehagen; Ola Myklebost; Leonardo A Meza-Zepeda
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

10.  Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.

Authors:  Shih-Chiang Huang; Lei Zhang; Yun-Shao Sung; Chun-Liang Chen; Yu-Chien Kao; Narasimhan P Agaram; Samuel Singer; William D Tap; Sandra D'Angelo; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2016-05       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.